Literature DB >> 11956985

Influence of aeration, storage, and rinsing conditions on residual ethylene oxide in freeze-dried bone allograft.

Nobuhiro Kaku1, Hiroshi Tsumura, Masashi Kataoka, Hirofumi Taira, Takehiko Torisu.   

Abstract

Bone allografts sterilized with ethylene oxide gas (EO) are used in the field of orthopedic surgery, and the reduction of the EO residual concentration is an urgent clinical matter. We therefore investigated the efficacy of aeration and the effects of varied preservation periods and rinsing conditions on the reduction of EO residuals in freeze-dried bone allografts in the present study. Before aeration, the EO residual level was 12.6 ppm, and, after the repeating of aeration at 60 degrees C once, two times, and three times, the level decreased to 10.9 ppm, 3.1 ppm, and 0.47 ppm, respectively. Regarding the duration of preservation at room temperature, the mean EO residual level was 10.5 ppm, 4.9 ppm, and 4.6 ppm, 1, 2, and 3 weeks after EO sterilization, respectively. By rinsing with physiological salt solution, the level was decreased to 6.9 ppm by 5-min rinsing with 100 ml. Rinsing with 500 ml of this solution decreased the levels to 3.9 ppm, 2.8 ppm, and 2.0 ppm when done for 1, 5, and 10 min, respectively. Rinsing with 2000 ml of this solution decreased the levels to 3.6 ppm, 2.6 ppm, and 1.7 ppm when done for 1, 5, and 10 min, respectively. These experimental results with chip bone allografts lead us to recommend repeated preoperative aeration and more than 2 weeks' preservation before use for reducing the residual EO concentration. It was also evident that intraoperative rinsing with 500 ml of physiological saline for 10 min reduced the EO residual level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956985     DOI: 10.1007/s007760200039

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  1 in total

1.  Surgery in a patient allergic to ethylene oxide.

Authors:  Vanessa Demontoux; Emilie Moreau; Isabelle Peyron; Valérie Talon; Nejib Khouri; Jean-Paul Morin; Yvonnick Bézie
Journal:  Pharm World Sci       Date:  2007-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.